Cargando…

Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study

BACKGROUND: The long‐term prognosis of refractory hypertension (RfHT), defined as failure to control blood pressure (BP) levels despite an antihypertensive treatment with ≥5 medications including a diuretic and mineraloreceptor antagonist, has never been evaluated. METHODS AND RESULTS: In a prospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardoso, Claudia R. L., Salles, Gil F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660786/ https://www.ncbi.nlm.nih.gov/pubmed/32851922 http://dx.doi.org/10.1161/JAHA.120.017634

Ejemplares similares

Burden of hypertension and associated risks for cardiovascular mortality in Cuba: a prospective cohort study
por: Armas Rojas, Nurys, et al.
Publicado: (2019)

Association of heart rate with cardiovascular events and mortality in hypertensive and normotensive population: a nationwide prospective cohort study
por: Wang, Yuebo, et al.
Publicado: (2021)

A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension
por: Jiao, Jie, et al.
Publicado: (2022)

Association of Uncontrolled Hypertension or Diabetes Mellitus With Major Adverse Cardiovascular Events and Mortality in South Korea: Population-Based Cohort Study
por: Oh, Sung-Hee, et al.
Publicado: (2023)

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus
por: Bakris, George, et al.
Publicado: (2023)

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
por: Hashemi Madani, Nahid, et al.
Publicado: (2020)

Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort
por: Lee, Jin Young, et al.
Publicado: (2023)

Predictors of Cardiovascular Events in Hypertensive Patients with High Cardiovascular Risk
por: Tasić, Ivan, et al.
Publicado: (2020)

Decreased Glomerular Filtration Rate Is Associated with Mortality and Cardiovascular Events in Patients with Hypertension: A Prospective Study
por: Zhang, Rui, et al.
Publicado: (2011)

Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk
por: Elijovich, Fernando, et al.
Publicado: (2020)

Prognostic impact of changes in aortic stiffness for cardiovascular and mortality outcomes in individuals with type 2 diabetes: the Rio de Janeiro cohort study
por: Cardoso, Claudia R L, et al.
Publicado: (2022)

Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and non-resistant hypertension
por: Sim, John J., et al.
Publicado: (2015)

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
por: Basile, Jan, et al.
Publicado: (2018)

Effect of Heart Rate on Major Adverse Cardiovascular Events in Hypertensive Patients with Different Ages and Genders
por: Xi, Yang, et al.
Publicado: (2021)

An Update on Refractory Hypertension
por: Matanes, Faris, et al.
Publicado: (2022)

The prognostic values of beta-2 microglobulin for risks of cardiovascular events and mortality in the elderly patients with isolated systolic hypertension
por: Wang, Hai-Jun, et al.
Publicado: (2018)

Prognostic Importance of C‐Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2016)

Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease
por: Jehan, Shazia, et al.
Publicado: (2020)

Homocysteine, hypertension, and risks of cardiovascular events and all-cause death in the Chinese elderly population: a prospective study
por: ZHANG, Zhong-Ying, et al.
Publicado: (2021)

Resistant and refractory hypertension: two sides of the same disease?
por: Muxfeldt, Elizabeth Silaid, et al.
Publicado: (2018)

Recent advances in understanding and managing resistant/refractory hypertension
por: Doumas, Michael, et al.
Publicado: (2020)

Prediabetes and risk for all-cause and cardiovascular mortality based on hypertension status
por: Huang, Yu-Qing, et al.
Publicado: (2020)

Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients
por: Tepel, Martin, et al.
Publicado: (2008)

COPD significantly increases cerebral and cardiovascular events in hypertensives
por: Perticone, Maria, et al.
Publicado: (2021)

How much does hypertension in pregnancy affect the risk of future cardiovascular events?
por: Mureddu, Gian Francesco
Publicado: (2023)

Association of constipation with increased risk of hypertension and cardiovascular events in elderly Australian patients
por: Judkins, Courtney P., et al.
Publicado: (2023)

Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population
por: Doran, Stacey, et al.
Publicado: (2023)

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension
por: Wang, Xiaopu, et al.
Publicado: (2021)

Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
por: Yang, Kun, et al.
Publicado: (2021)

The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD)
por: Andersson, Tobias, et al.
Publicado: (2020)

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2021)

Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance
por: Calhoun, David A.
Publicado: (2016)

Longitudinal Trends in Hypertension Management and Mortality Among Octogenarians: Prospective Cohort Study
por: Dregan, Alex, et al.
Publicado: (2016)

Effects of Weight Loss and Interaction with Physical Activity on Risks of Cardiovascular Outcomes in Individuals with Type 2 Diabetes
por: Cardoso, Claudia R. L., et al.
Publicado: (2023)

Prevalence of isolated diastolic hypertension and the risk of cardiovascular mortality among adults aged 40 years and older in northeast China: a prospective cohort study
por: Yue, Ling, et al.
Publicado: (2022)

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study
por: Zheng, Yan, et al.
Publicado: (2022)

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality
por: Huang, Yuli, et al.
Publicado: (2017)

Associations of Serum Carotenoids With Risk of All‐Cause and Cardiovascular Mortality in Hypertensive Adults
por: Zhu, Xu, et al.
Publicado: (2023)

7(th) Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial Hypertension
por: Malachias, MVB, et al.
Publicado: (2016)

Analysis of Aspirin Use and Cardiovascular Events and Mortality Among Adults With Hypertension and Controlled Systolic Blood Pressure
por: Del Pinto, Rita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4sf0o46u7261787hcuqt7qmnlj